News
The FDA has cleared an accelerated protocol for a transcranial magnetic stimulation system in the treatment of depression and ...
Zacks Investment Research on MSN
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay Ltd. BWAY recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic ...
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression ...
TORRINGTON, Conn., July 5, 2022 /PRNewswire/ -- Therap Services, the leading organization providing electronic documentation solutions for agencies in the Long-Term Services and Supports (LTSS), Home ...
BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results